Molecular Imaging Market Size, Share & Trends Analysis Report By Modality (SPECT, NMR), By Application (Oncology, Cardiology), By End-use (Hospitals, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Molecular Imaging Market Growth & Trends
The global molecular imaging market size is anticipated t%li%reach USD 11.44 billion by 2030, growing at a CAGR of 4.52% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The major factors contributing t%li%market growth include technological advancements, increase in prevalence of cancer, and rising investment in R&D. For instance, according t%li%the International Agency for Research on Cancer, approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths were reported globally in 2022.
The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates effective diagnostic tools, which are expected t%li%significantly contribute t%li%the growth of the molecular imaging market. Molecular imaging devices such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and Nuclear Magnetic Resonance (NMR) Spectrometer are particularly efficient in this regard. These advanced technologies provide detailed insights int%li%the metabolic processes, molecular activities, and structural changes associated with various diseases. They enable healthcare professionals t%li%visualize and assess the extent and characteristics of tumors, cardiac function, and neurological abnormalities with high precision and accuracy.
Moreover, molecular imaging facilitates early detection of diseases, even at subclinical stages, allowing for timely intervention and personalized treatment planning. This proactive approach not only improves patient outcomes but als%li%reduces healthcare costs associated with advanced disease stages and complications.
Strategic initiatives undertaken by major market players, including mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, and research and development (R&D) activities, play a crucial role in driving the growth of the molecular imaging market. For instance, in January 2024, Bruker Corporation successfully installed a state-of-the-art 1.2 Gigahertz (GHz) NMR system at The Ohi%li%State University's National Gateway Ultrahigh Field NMR Center. This GHz-class NMR system represents a significant advancement in nuclear magnetic resonance (NMR) spectroscopy, aiming t%li%revolutionize research in life sciences and materials science.
Molecular Imaging Market Report Highlights
Molecular Imaging Market Growth & Trends
The global molecular imaging market size is anticipated t%li%reach USD 11.44 billion by 2030, growing at a CAGR of 4.52% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The major factors contributing t%li%market growth include technological advancements, increase in prevalence of cancer, and rising investment in R&D. For instance, according t%li%the International Agency for Research on Cancer, approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths were reported globally in 2022.
The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates effective diagnostic tools, which are expected t%li%significantly contribute t%li%the growth of the molecular imaging market. Molecular imaging devices such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and Nuclear Magnetic Resonance (NMR) Spectrometer are particularly efficient in this regard. These advanced technologies provide detailed insights int%li%the metabolic processes, molecular activities, and structural changes associated with various diseases. They enable healthcare professionals t%li%visualize and assess the extent and characteristics of tumors, cardiac function, and neurological abnormalities with high precision and accuracy.
Moreover, molecular imaging facilitates early detection of diseases, even at subclinical stages, allowing for timely intervention and personalized treatment planning. This proactive approach not only improves patient outcomes but als%li%reduces healthcare costs associated with advanced disease stages and complications.
Strategic initiatives undertaken by major market players, including mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, and research and development (R&D) activities, play a crucial role in driving the growth of the molecular imaging market. For instance, in January 2024, Bruker Corporation successfully installed a state-of-the-art 1.2 Gigahertz (GHz) NMR system at The Ohi%li%State University's National Gateway Ultrahigh Field NMR Center. This GHz-class NMR system represents a significant advancement in nuclear magnetic resonance (NMR) spectroscopy, aiming t%li%revolutionize research in life sciences and materials science.
Molecular Imaging Market Report Highlights
- Based on the modality segment, the Single Photon Emission Computed Tomography (SPECT) segment dominated by capturing a share of 43.8% in 2023
- The Nuclear Magnetic Resonance (NMR) Spectrometer segment is anticipated t%li%grow at the fastest CAGR from 2024 t%li%2030
- Based on application, the oncology segment held the largest market share in the application segment by capturing a share of 33.7% in 2023.
- Based on end use, the hospital segment held a majority share of the market in 2023.
- Diagnostic imaging centers segment is expected t%li%grow at the fastest rate from 2024 t%li%2030
- North America dominated the market with a share of 41.7% in 2023.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Modality
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. MOLECULAR IMAGING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cancer and other chronic diseases
3.2.1.2. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Equipment and Treatment
3.3. Molecular Imaging Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. MOLECULAR IMAGING MARKET: MODALITY ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Molecular Imaging Modality Market Movement Analysis
4.3. Global Molecular Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
4.4. Molecular Ultrasound Imaging
4.4.1. Molecular ultrasound imaging market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Positron Emission Tomography (PET)
4.5.1. Positron emission tomography (PET) market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Single Photon Emission Computed Tomography (SPECT)
4.6.1. Single photon emission computed tomography (SPECT) market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Nuclear Magnetic Resonance (NMR) Spectrometer
4.7.1. Nuclear Magnetic resonance (NMR) spectrometer market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Other Modalities
4.8.1. Other modalities market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. MOLECULAR IMAGING MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Molecular Imaging Application Market Movement Analysis
5.3. Global Molecular Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cardiovascular
5.4.1. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Neurology
5.5.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Oncology
5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Respiratory
5.7.1. Respiratory market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Gastrointestinal
5.8.1. Gastrointestinal market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. MOLECULAR IMAGING MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Molecular Imaging End Use Market Movement Analysis
6.3. Global Molecular Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Diagnostic Imaging Centers
6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Research institutes
6.6.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. MOLECULAR IMAGING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY APPLICATION, END USE
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement structure
7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement structure
7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement structure
7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement structure
7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement structure
7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement structure
7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement structure
7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement structure
7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement structure
7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory framework
7.6.7.4. Reimbursement structure
7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Regulatory framework
7.6.8.4. Reimbursement structure
7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement structure
7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement structure
7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement structure
7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement structure
7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement structure
7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement structure
7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement structure
7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement structure
7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement structure
7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement structure
7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement structure
7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement structure
7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2023
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders
8.6. Company Profiles
8.6.1. Bruker
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. GE HealthCare
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. Siemens Healthineers
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. Koninklijke Philips N.V.
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. Canon Medical Systems Corporation
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. Mediso, Cubresa Inc.
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. Shimadzu Corporation
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. United Imaging Healthcare Co
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. Positron Corporation
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Modality
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. MOLECULAR IMAGING MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cancer and other chronic diseases
3.2.1.2. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Equipment and Treatment
3.3. Molecular Imaging Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. MOLECULAR IMAGING MARKET: MODALITY ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Molecular Imaging Modality Market Movement Analysis
4.3. Global Molecular Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
4.4. Molecular Ultrasound Imaging
4.4.1. Molecular ultrasound imaging market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Positron Emission Tomography (PET)
4.5.1. Positron emission tomography (PET) market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Single Photon Emission Computed Tomography (SPECT)
4.6.1. Single photon emission computed tomography (SPECT) market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Nuclear Magnetic Resonance (NMR) Spectrometer
4.7.1. Nuclear Magnetic resonance (NMR) spectrometer market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Other Modalities
4.8.1. Other modalities market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. MOLECULAR IMAGING MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Molecular Imaging Application Market Movement Analysis
5.3. Global Molecular Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cardiovascular
5.4.1. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Neurology
5.5.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Oncology
5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Respiratory
5.7.1. Respiratory market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Gastrointestinal
5.8.1. Gastrointestinal market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. MOLECULAR IMAGING MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Molecular Imaging End Use Market Movement Analysis
6.3. Global Molecular Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Diagnostic Imaging Centers
6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Research institutes
6.6.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. MOLECULAR IMAGING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY APPLICATION, END USE
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement structure
7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement structure
7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement structure
7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement structure
7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement structure
7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement structure
7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement structure
7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement structure
7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement structure
7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory framework
7.6.7.4. Reimbursement structure
7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Regulatory framework
7.6.8.4. Reimbursement structure
7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement structure
7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement structure
7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement structure
7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement structure
7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement structure
7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement structure
7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement structure
7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement structure
7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement structure
7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement structure
7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement structure
7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement structure
7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2023
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders
8.6. Company Profiles
8.6.1. Bruker
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. GE HealthCare
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. Siemens Healthineers
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. Koninklijke Philips N.V.
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. Canon Medical Systems Corporation
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. Mediso, Cubresa Inc.
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. Shimadzu Corporation
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. United Imaging Healthcare Co
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. Positron Corporation
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 4 North America molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 5 North America molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 6 North America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 7 U.S. molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 8 U.S. molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 9 U.S. molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 10 Canada molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 11 Canada molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 12 Canada molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 13 Mexico molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 14 Mexico molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 15 Mexico molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 16 Europe molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 17 Europe molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 18 Europe molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 19 Europe molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 20 UK molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 21 UK molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 22 UK molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 23 Germany molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 24 Germany molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 25 Germany molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 26 France molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 27 France molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 28 France molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 29 Italy molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 30 Italy molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 31 Italy molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 32 Denmark molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 33 Denmark molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 34 Denmark molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 35 Sweden molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 36 Sweden molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 37 Sweden molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 38 Norway molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 39 Norway molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 40 Norway molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 41 Asia Pacific molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 42 Asia Pacific molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 43 Asia Pacific molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 44 Asia Pacific molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 45 Japan molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 46 Japan molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 47 Japan molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 48 China molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 49 China molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 50 China molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 51 India molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 52 India molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 53 India molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 54 Australia molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 55 Australia molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 56 Australia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 57 South Korea molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 58 South Korea molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 59 South Korea molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 60 Thailand molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 61 Thailand molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 62 Thailand molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 63 Latin America molecular imaging market, By Country, 2018 - 2030 (USD Million)
Table 64 Latin America molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 65 Latin America molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 66 Latin America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 67 Brazil molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 68 Brazil molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 69 Brazil molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 70 Argentina molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 71 Argentina molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 72 Argentina molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 73 Middle East & Africa molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 74 Middle East & Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 75 Middle East & Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 76 Middle East & Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 77 South Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 78 South Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 79 South Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 80 Saudi Arabia molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 83 UAE molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 84 UAE molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 85 UAE molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 86 Kuwait molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 87 Kuwait molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 88 Kuwait molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 4 North America molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 5 North America molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 6 North America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 7 U.S. molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 8 U.S. molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 9 U.S. molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 10 Canada molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 11 Canada molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 12 Canada molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 13 Mexico molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 14 Mexico molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 15 Mexico molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 16 Europe molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 17 Europe molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 18 Europe molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 19 Europe molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 20 UK molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 21 UK molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 22 UK molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 23 Germany molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 24 Germany molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 25 Germany molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 26 France molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 27 France molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 28 France molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 29 Italy molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 30 Italy molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 31 Italy molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 32 Denmark molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 33 Denmark molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 34 Denmark molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 35 Sweden molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 36 Sweden molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 37 Sweden molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 38 Norway molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 39 Norway molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 40 Norway molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 41 Asia Pacific molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 42 Asia Pacific molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 43 Asia Pacific molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 44 Asia Pacific molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 45 Japan molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 46 Japan molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 47 Japan molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 48 China molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 49 China molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 50 China molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 51 India molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 52 India molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 53 India molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 54 Australia molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 55 Australia molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 56 Australia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 57 South Korea molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 58 South Korea molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 59 South Korea molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 60 Thailand molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 61 Thailand molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 62 Thailand molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 63 Latin America molecular imaging market, By Country, 2018 - 2030 (USD Million)
Table 64 Latin America molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 65 Latin America molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 66 Latin America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 67 Brazil molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 68 Brazil molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 69 Brazil molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 70 Argentina molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 71 Argentina molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 72 Argentina molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 73 Middle East & Africa molecular imaging market, By country, 2018 - 2030 (USD Million)
Table 74 Middle East & Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 75 Middle East & Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 76 Middle East & Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 77 South Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 78 South Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 79 South Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 80 Saudi Arabia molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 83 UAE molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 84 UAE molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 85 UAE molecular imaging market, By end-use, 2018 - 2030 (USD Million)
Table 86 Kuwait molecular imaging market, By modality, 2018 - 2030 (USD Million)
Table 87 Kuwait molecular imaging market, By application, 2018 - 2030 (USD Million)
Table 88 Kuwait molecular imaging market, By end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Transcatheter aortic valve replacement market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Transcatheter aortic valve replacement market: Implantation Procedure outlook key takeaways
Fig. 20 Transcatheter aortic valve replacement market: Implantation Procedure movement analysis
Fig. 21 Transfemoral market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Transapical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 23 Transaortic market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 24 Transcatheter aortic valve replacement market: Material outlook key takeaways
Fig. 25 Transcatheter aortic valve replacement market: Material movement analysis
Fig. 26 Nitinol market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 27 Cobalt chromium market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 28 Stainless steel market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 30 Transcatheter aortic valve replacement market: Mechanism outlook key takeaways
Fig. 31 Transcatheter aortic valve replacement market: Mechanism movement analysis
Fig. 32 Balloon-expandable market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 33 Self-expandable market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 34 Transcatheter aortic valve replacement market: End-use outlook key takeaways
Fig. 35 Transcatheter aortic valve replacement market: End-use movement analysis
Fig. 36 Hospitals market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 37 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 39 Regional marketplace outlook, 2023 & 2030 (USD Billion)
Fig. 40 Regional marketplace: Key takeaways
Fig. 41 North America transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 42 Key country dynamics
Fig. 43 U.S. transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 44 Key country dynamics
Fig. 45 Canada transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 46 Key country dynamics
Fig. 47 Mexico transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 48 Europe transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 49 Key country dynamics
Fig. 50 UK transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 51 Key country dynamics
Fig. 52 Germany transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 53 Key country dynamics
Fig. 54 France transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 55 Key country dynamics
Fig. 56 Spain transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 57 Key country dynamics
Fig. 58 Italy transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 59 Key country dynamics
Fig. 60 Denmark transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 61 Key country dynamics
Fig. 62 Sweden transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 63 Key country dynamics
Fig. 64 Norway transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 65 Asia Pacific transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 66 Key country dynamics
Fig. 67 Japan transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 68 Key country dynamics
Fig. 69 China transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 70 Key country dynamics
Fig. 71 India transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 72 Key country dynamics
Fig. 73 Australia transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 74 Key country dynamics
Fig. 75 South Korea transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 76 Key country dynamics
Fig. 77 Thailand transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 78 Key country dynamics
Fig. 79 Market participant categorization
Fig. 80 Transcatheter aortic valve replacement market position analysis, 2023
Fig. 81 Strategic framework
Fig. 1 Transcatheter aortic valve replacement market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Transcatheter aortic valve replacement market: Implantation Procedure outlook key takeaways
Fig. 20 Transcatheter aortic valve replacement market: Implantation Procedure movement analysis
Fig. 21 Transfemoral market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Transapical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 23 Transaortic market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 24 Transcatheter aortic valve replacement market: Material outlook key takeaways
Fig. 25 Transcatheter aortic valve replacement market: Material movement analysis
Fig. 26 Nitinol market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 27 Cobalt chromium market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 28 Stainless steel market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 30 Transcatheter aortic valve replacement market: Mechanism outlook key takeaways
Fig. 31 Transcatheter aortic valve replacement market: Mechanism movement analysis
Fig. 32 Balloon-expandable market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 33 Self-expandable market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 34 Transcatheter aortic valve replacement market: End-use outlook key takeaways
Fig. 35 Transcatheter aortic valve replacement market: End-use movement analysis
Fig. 36 Hospitals market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 37 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 39 Regional marketplace outlook, 2023 & 2030 (USD Billion)
Fig. 40 Regional marketplace: Key takeaways
Fig. 41 North America transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 42 Key country dynamics
Fig. 43 U.S. transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 44 Key country dynamics
Fig. 45 Canada transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 46 Key country dynamics
Fig. 47 Mexico transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 48 Europe transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 49 Key country dynamics
Fig. 50 UK transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 51 Key country dynamics
Fig. 52 Germany transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 53 Key country dynamics
Fig. 54 France transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 55 Key country dynamics
Fig. 56 Spain transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 57 Key country dynamics
Fig. 58 Italy transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 59 Key country dynamics
Fig. 60 Denmark transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 61 Key country dynamics
Fig. 62 Sweden transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 63 Key country dynamics
Fig. 64 Norway transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 65 Asia Pacific transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 66 Key country dynamics
Fig. 67 Japan transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 68 Key country dynamics
Fig. 69 China transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 70 Key country dynamics
Fig. 71 India transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 72 Key country dynamics
Fig. 73 Australia transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 74 Key country dynamics
Fig. 75 South Korea transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 76 Key country dynamics
Fig. 77 Thailand transcatheter aortic valve replacement market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 78 Key country dynamics
Fig. 79 Market participant categorization
Fig. 80 Transcatheter aortic valve replacement market position analysis, 2023
Fig. 81 Strategic framework
